The pitch is straightforward. For a professional who wants to avoid the jitters of a third coffee, or a student cramming for finals, a piece of gum is a simpler, faster, and more portable solution than a drink. Neuro Gum & Mints has spent the last nine years building a business on that premise, turning a functional supplement into a consumer packaged good you can find at the CVS checkout. The bet is that convenience, backed by specific doses of ingredients like caffeine and L-theanine, can carve out a durable slot in the crowded wellness aisle. The early returns, if the company's reported figures are accurate, suggest the wedge is working.
Founded in 2015 by lifelong friends and athletes Kent Yoshimura and Ryan Chen, Neuro started as a direct-to-consumer brand. The core innovation was format: delivering nootropic and adaptogenic ingredients through sugar-free, aspartame-free chewing gum and mints.
| Metric | Value |
|---|---|
| Energy & Focus Gum | 60 mg L-theanine |
| Calm & Clarity Gum | 130 mg GABA |
| Memory & Focus Gum | 200 mg ginseng |
The wedge of convenience and clinical dosing
Neuro's primary competition isn't other gum companies. It's the energy drink in the cooler and the coffee pot in the break room. The company positions its products as a cleaner, steadier alternative, promising focus without a crash [neurogum.com]. The real differentiation lies in the combination of delivery method and transparent, science-adjacent dosing. By publishing the milligram amounts of key ingredients, Neuro appeals to a biohacking-curious audience that reads labels.
Traction beyond the DTC playbook
For a company that appears to have operated largely without traditional venture capital until recently, Neuro's retail footprint is notable. The brand is now carried by major national chains including CVS, Walmart, Whole Foods, Target, and Albertsons [neurogum.com]. Multiple sources, including a 2026 Inc. profile, state the company brings in over $10 million in revenue each month, with annual revenue projected at approximately $120 million [Inc.com, 2026]. A seed round of roughly $8.3 million was reported in 2023 [tracxn.com, 2026].
The founder-led operational thesis
The company's narrative is deeply tied to its founders' backgrounds. CEO Kent Yoshimura is a multimedia artist and former competitive judoka [medium.com, 2026]. COO Ryan Chen is a former Paralympic training athlete [voyagela.com, 2026]. Scaling a CPG brand into national retail requires expertise in logistics, broker relationships, and trade spend management. The team's ability to navigate this, evidenced by their shelf placement, suggests they have built or hired that competency.
The crowded field and the durability question
The functional gum space is not uncontested. Neuro's realistic competitive set includes several other players aiming for the same consumer need state.
| Competitor | Primary Claim / Differentiation |
|---|---|
| Run Gum | Energy gum founded by an Olympic athlete, focused on caffeine for athletic performance. |
| Viter Energy | Caffeine-infused mints, often marketed as a coffee alternative. |
| WUG Functional Gums | Variety of functional ingredients in gum format. |
| Military Energy Gum | Very high caffeine content targeted at specific tactical use. |
Neuro's most credible risk isn't a direct competitor, but the classic CPG challenge of sustaining brand relevance and shelf space in a category prone to fads. Their appearance on Shark Tank in 2020 provided a national awareness boost that likely aided early retail conversations [instagram.com].
What enterprise buyers are saying
For inventory managers at regional grocery chains or category merchants at national drugstores, Neuro represents a high-margin SKU in the growing wellness segment. The product's format allows for placement in multiple parts of the store, which increases its sales potential per square foot. The real test for Neuro's account managers will be proving repeat purchase rates and defending their facings against the next wave of functional snacks. For now, the reported $10 million monthly run rate suggests they are winning that argument at the buyer level.
Looking ahead, the next twelve months will test the brand's durability. The company must demonstrate that its products drive repeat purchases, not just novelty trials. With a reported seed round now behind it, the company has capital to invest in brand marketing and trade promotions to secure its position. In a market crowded with promises of better focus and energy, Neuro has managed to get its promise onto physical shelves where the battle for consumer attention is fought daily.